67 studies found for:    "Living Donors" | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney
Conditions: Acute Kidney Injury;   Liver Transplantation;   Terlipressin;   NGAL
Interventions: Drug: Terlipressin;   Drug: placebo
22 Unknown  Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes
Condition: Renal Transplantation
Intervention: Drug: TAIZ
23 Recruiting The ONE Study ATDC Trial
Condition: Renal Failure, End Stage
Intervention: Biological: ATDC_Nantes
24 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF
25 Unknown  Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
Condition: Kidney Failure, Chronic
Intervention: Drug: Thymoglobulin
26 Recruiting Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction
Conditions: Liver Transplant Recipient;   Living Donor (of the Respective Liver Transplant Recipient)
Interventions: Biological: darTregs;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Immunosuppression (IS) Withdrawal;   Procedure: Study Mandated Procedures
27 Recruiting Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation
Condition: Pediatric Liver Transplantation
Intervention: Drug: Tacrolimus
28 Recruiting Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge
Condition: End Stage Renal Disease
Interventions: Other: Patient-Guided;   Other: Educator-Guided
29 Recruiting Vasodilator-induced Hypovolemia in Living Liver Donors
Conditions: CVP and SVV During Living Donor Hepatectomy;   Surgical Field Grade (Condition of Surgical Field; Bleeding, Tension of the IVC)
Intervention: Procedure: vasodilator induced hypovolemia
30 Recruiting A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Hepatic Protection During Living-donor Liver Transplantation
Condition: End Stage Liver Disease
Interventions: Drug: Desflurane balanced anesthesia;   Drug: Propofol total intravenous anesthesia
31 Not yet recruiting Radio-Immuno-Modulation in Lung Cancer
Condition: Lung Cancer
Interventions: Other: Patients with a living donor;   Other: Patients with a UCB donor
32 Recruiting Omega 3 Lipid Emulsions and Liver Transplantation
Condition: Ischemia Re-perfusion Injury
Interventions: Dietary Supplement: SMOFLipid;   Dietary Supplement: equilevant volume of 10% glucose solution
33 Recruiting Lipids and Neurological Complications in Liver Transplantation
Condition: Neurological Complications
Intervention: Drug: SMOF lipid (SMOFLIPID) pre treatment
34 Unknown  Adrenal Function After Living Kidney Donation
Conditions: Addison Disease;   Hypoaldosteronism
Intervention: Procedure: Laparoscopic hand-assisted donor nephrectomy
35 Recruiting Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
Condition: Immune Tolerance
Intervention: Device: Immune tolerance
36 Recruiting Transplant Social Worker Support for Live Kidney Donation in African Americans
Condition: Kidney Disease
Interventions: Behavioral: TALKS Social Worker Intervention;   Other: Financial Assistance Intervention
37 Recruiting Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation
Conditions: Deceased Donor Kidney Transplantation;   Living Donor Kidney Transplantation
Intervention: Procedure: kidney transplantation, living or deceased donor
38 Not yet recruiting Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation
Condition: Liver Transplantation
Interventions: Drug: Propofol;   Drug: dexmedetomedine
39 Unknown  Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant
Conditions: Transplantation, Homologous;   Immunosuppression
Intervention: Drug: everolimus
40 Recruiting The ONE Study M Reg Trial
Condition: Renal Failure, End Stage
Intervention: Biological: Donor M reg (Mreg_UKR)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years